Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Hu, M.Y.

Search results

  • RSS Feed
(1 - 4 of 4)
Unextendible product operator basis
Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
Sustained Fracture Risk Reduction with Sequential Abaloparatide/Alendronate: Results of ACTIVExtend